Starling Oncology (STLNW) EBIT Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 12.63% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 17.32% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 11.72% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 11.91% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 19.04% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 5.48% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 38.11% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | 1.51% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | 3.04% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 32.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.39% |
| Mar 31, 2026 | 41.70% |
| Dec 31, 2025 | 34.94% |
| Sep 30, 2025 | 26.27% |
| Jun 30, 2025 | 15.08% |
| Mar 31, 2025 | 18.74% |
| Dec 31, 2024 | 33.65% |
| Sep 30, 2024 | -85.88% |
| Jun 30, 2024 | -144.76% |
| Mar 31, 2024 | -117.24% |
| Dec 31, 2023 | -25.60% |
| Sep 30, 2023 | -312.44% |
| Jun 30, 2023 | -325.02% |